Find similar products:
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 11243/0021.
Amfexa 5mg Tablets
Amfexa 5 mg tablets
Dexamfetamine sulfate
1. What an Amfexa 5 mg tablet is and what it is used for
2. What you need to know before you take Amfexa 5 mg tablets
3. How to take Amfexa 5 mg tablets
4. Possible side effects
5. How to store Amfexa 5 mg tablets
6. Contents of the pack and other information
Amfexa 5 mg tablets contain the active substance dexamfetamine sulfate.
Amfexa is a psychostimulant. It improves activity in parts of the brain. This medicine can help to improve attention span, concentration, and reduce impulsive behaviour.
Amfexa 5 mg tablets are used to treat attention-deficit/hyperactivity disorder (ADHD).
Treatment with Amfexa 5 mg tablets must only be initiated by, and used under the supervision of a specialist in childhood or adolescent behavioural disorders.
You must talk to a specialist if your child and/or adolescent does not feel better or if they feel worse after a month. The specialist may decide that a different treatment is needed.
Do not use this medicine if any of the above applies to your child and/or adolescent. If you are not sure, talk to your specialist or pharmacist before you use Amfexa 5 mg tablets. This is because this medicine can make these problems worse.
Talk to your specialist or pharmacist before taking Amfexa 5 mg tablets if your child and/or adolescent
Tell your specialist or pharmacist if any of the above applies to your child and/or adolescent before starting treatment. This is because this medicine can make these problems worse. Your specialist will want to monitor how the medicine affects your child and/or adolescent.
Checks that your specialist will make before Amfexa 5 mg tablets are given
These checks are to decide if this is the correct medicine for your child and/or adolescent. Your specialist will talk to you about:
Your specialist will discuss whether your child and/or adolescent is at risk of having mood swings (from being manic to being depressed - called ‘bipolar disorder’). They will check your child and/or adolescent’s mental health history, and check if any of your family has a history of suicide, bipolar disorder or depression.
It is important that you provide as much information as you can. This will help your specialist decide if Amfexa 5 mg tablets are the correct medicine for your child and/or adolescent. Your specialist may decide that other medical tests are needed before they start taking this medicine.
Effect on weight/growing
Amfexa 5 mg tablets may cause reduced weight in some children and adolescents.
Having an operation
Tell your specialist if your child and/or adolescent is going to have an operation. Amfexa 5 mg tablets should not be taken on the day of surgery if a certain type of anaesthetic is used. This is because there is a chance of a sudden rise in blood pressure during the operation.
Drug testing
This medicine may give a positive result when testing for drug use.
Drug/laboratory test interactions
This medicine may interfere with your laboratory test results.
Amfexa 5 mg tablets are not for use as a treatment for ADHD in children under 6 years of age, and adults. It is not known if it is safe or of benefit for these people.
Tell your specialist or pharmacist if your child and/or adolescent is taking, has recently taken or might take any other medicines, including medicines obtained without a prescription.
Monoamine oxidase inhibitors
Do not use this medicine if your child and/or adolescent is taking a medicine called a ‘monoamine oxidase inhibitor’ (MAOI) used for depression or has taken an MAOI in the last 14 days. Taking an MAOI with dexamfetamine may cause a sudden increase in blood pressure.
If your child and/or adolescent is taking other medicines, this medicine may affect how well they work or may cause side effects. If your child and/or adolescent is taking any of the following medicines, check with your specialist or pharmacist before using Amfexa 5 mg tablets:
If you are in any doubt about whether any medicines your child and/or adolescent is taking are included in the list above, ask your specialist or pharmacist for advice before taking this medicine.
Alcohol must not be consumed while taking this medicine. Remember that some foods and medicines contain alcohol.
Available data from the use of Amfexa 5 mg tablets during the first three months of pregnancy do not indicate increased risk of congenital malformation in the child and/or adolescent but may increase the risk for pre-eclampsia (a condition usually occurring after 20 weeks of pregnancy characterized by high blood pressure and protein in the urine) and preterm birth. New-borns exposed to amfetamine during pregnancy may experience withdrawal symptoms (changes in behaviour including excessive crying, unstable or irritable mood, hyperexcitability and pronounced exhaustion).
If your daughter is pregnant or breast–feeding, she may be pregnant or is planning to have a baby, ask your specialist or pharmacist for advice before using this medicine.
Your child and/or adolescent may feel dizzy, have problems focussing, or have blurred vision when taking this medicine. If so, it may be dangerous to do things such as drive, use machines, ride a bike or horse, or climb trees.
The medicine can affect your ability to drive as it may make you sleepy or dizzy.
Talk to your specialist or pharmacist if you are not sure whether it is safe for you to drive while taking this medicine.
If you have been told by your specialist that your child and/or adolescent cannot tolerate some sugars, talk to your specialist before using this medicinal product.
Always use this medicine exactly as your specialist has told you. You should check with your specialist or pharmacist if you are not sure.
The normal recommended dose is between 5 mg and 20 mg.
The medicinal product is intended for oral use.
The tablet should be taken with a drink of water, preferably with or immediately after meals. Amfexa 5 mg tablets should be taken at the same time in relation to the meals. The last dose should, in general, not be given too late after lunch in order to prevent disturbances in falling asleep.
The tablets have a score line and can be divided, if needed. The score line is only there to help you break the tablet if there is difficulty swallowing it whole. To split it, place the tablet on a solid surface with the cross-scored, smooth side downwards and then push carefully with your index finger at the centre of its top side. The tablet then breaks into four parts.
If your child and/or adolescent does not feel better, tell your specialist. They may decide a different treatment is needed.
Your specialist will decide how long the treatment is given. If your child and/or adolescent takes this medicine for more than a year, your specialist should stop treatment for a short time, e.g. during a school holiday. This will show if the medicine is still needed.
If Amfexa 5 mg tablets are not taken properly, it may cause abnormal behaviour. It may also mean that your child and/or adolescent can become dependent on the medicine. Tell your specialist if your child and/or adolescent has ever abused or been dependent on alcohol, prescription medicines or street drugs.
This medicine is only for your child and/or adolescent. Do not give this medicine to anyone else, even if their symptoms seem similar.
Talk to a specialist or call an ambulance straight away. Tell them how much has been taken. Show the package or this leaflet to the specialist. Overdosage of these tablets can be very serious.
Signs of overdose may include: excitement, hallucinations, convulsions leading to coma, irregular and rapid heartbeat, and reduced breathing.
Do not use a double dose to make up for a forgotten dose. If your child and/or adolescent forgets a dose, wait until it is time for the next dose.
If your child and/or adolescent suddenly stops taking this medicine, this can lead to extreme tiredness, depression, mood disorders, agitation, sleep disturbances, increased appetite, or involuntary movements. Your specialist may want to gradually reduce the amount of medicine taken each day, before stopping it completely. Talk to your specialist before stopping Amfexa 5 mg tablets.
If you have any further questions on the use of this medicine, ask your specialist or pharmacist.
Like all medicines, this medicine can cause side effects, but not everybody gets them. Your specialist will talk to you about these side effects.
Stop taking Amfexa and immediately contact a specialist or go to the emergency centre if you experience the following symptoms:
Other side effects
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Not known: frequency cannot be estimated from the available data
If you get any side effects, talk to your specialist or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and the box after “EXP”. The expiry date refers to the last day of that month.
Do not store above 25°C.
Store in the original package in order to protect from moisture.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
Amfexa 5 mg tablets
White, round, cloverleaf-shaped tablets with a notched, cross-scored line on the top side and a cross-scored line embossed with “S” on each quarter on the rear side.
The tablets can be divided.
Pack sizes: 20, 28, 30, 50, 98 or 100 tablets
Boxes containing tablets packed in blisters made of PVC/PE/PVdC aluminium foil
Not all pack sizes may be marketed.
This package leaflet was last revised in 09/2023.
This medicinal product is authorised in the Member States of the EEA under the following names:
United Kingdom: Amfexa 5 mg tablet
Denmark: Attentin 5 mg
Finland: Attentin 5 mg
Iceland: Attentin 5 mg
Luxembourg: Attentin 5 mg
Norway: Attentin 5 mg
Sweden: Attentin 5 mg
This package leaflet is also available in formats appropriate for the blind and partially sighted.